The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Are The Market Size Estimates For The Predictive Genetic Counselling Market In 2026 And 2030?
The predictive genetic counselling market size has seen rapid growth in recent years. It is forecast to increase from $4.19 billion in 2025 to $4.87 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.2%. This historical growth can be attributed to factors like the increasing use of family history evaluation, the expansion of cancer risk screening programs, a growing acceptance of genetic testing, advancements in counseling methodologies, and rising public awareness of inherited diseases.
The predictive genetic counselling market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $8.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.9%. Factors contributing to this growth during the forecast period include the increasing incorporation of genomics into standard healthcare practices, the rising popularity of virtual counseling platforms, the broadening of preventive screening programs, the expanding application of AI-driven genetic interpretation, and a heightened demand for insights into personalized health risks. Key trends expected within this period encompass a surging demand for online genetic counseling services, an increase in the utilization of polygenic risk scoring, wider acceptance of direct-to-consumer genetic testing, the expansion of predictive oncology counseling, and a stronger emphasis on patient education and support for decision-making.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27397&type=smp
Which Key Factors Are Driving The Predictive Genetic Counselling Market Growth?
The increasing occurrence of genetic disorders is anticipated to fuel the expansion of the predictive genetic counselling market in the future. These conditions arise from alterations or flaws in an individual’s DNA, affecting bodily growth, development, and overall function. The surge in genetic disorders is attributed to rising parental age, as conceiving at an older age correlates with a greater probability of genetic mutations in offspring. Genetic disorders contribute to the development of predictive genetic counselling by boosting the need for risk assessment services, which assist people in comprehending their chances of inheriting or transmitting these conditions. For example, in October 2024, data from the Cystic Fibrosis Trust, a charitable organization based in the UK, revealed that the count of patients diagnosed with cystic fibrosis increased to 11,318 in 2023, an uplift from 11,148 recorded in 2022. Consequently, the escalating incidence of genetic disorders is propelling the predictive genetic counselling market.
What Segment Categories Shape The Predictive Genetic Counselling Market Segment Landscape?
The predictive genetic counselling market covered in this report is segmented –
1) By Service Type: Risk Assessment, Carrier Testing, Predictive Testing, Other Service Types
2) By Mode Of Delivery: In-Person, Online
3) By Application: Consumer Genomics, Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Applications
4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Risk Assessment: Family History Evaluation, Lifestyle And Environmental Risk Analysis, Polygenic Risk Score Analysis, Hereditary Disease Susceptibility Screening
2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Tay-Sachs Carrier Testing, Fragile X Syndrome Testing, Sickle Cell Carrier Testing, Thalassemia Carrier Screening
3) By Predictive Testing: Breast Cancer Gene 1 (BRCA1) Or Breast Cancer Gene 2 (BRCA2) Mutation Testing, Lynch Syndrome Testing, Huntington’s Disease Testing, Cardiovascular Genetic Risk Testing, Neurological Disorder Prediction Testing
4) By Other Service Types: Pharmacogenomic Testing, Prenatal Genetic Testing, Newborn Genetic Screening, Direct-To-Consumer Genetic Testing, Whole Genome Sequencing For Prediction
Which Trends Are Guiding The Direction Of The Predictive Genetic Counselling Market?
Leading firms within the predictive genetic counselling market are concentrating on creating sophisticated solutions, including the predictive genetic testing service, to facilitate early detection of disease risks and support well-informed clinical decisions. This service is defined as a medical procedure that examines an individual’s DNA to pinpoint genetic variations indicating a heightened probability of developing certain inherited conditions or illnesses later in life. An example occurred in August 2024 when Genetic Technologies Limited, an Australian company specializing in genomics-based health testing, introduced the geneType Risk Assessment test. This particular test functions as an unparalleled, exhaustive, multi-risk predictive genetic screening instrument, crafted to evaluate a person’s susceptibility to serious ailments like breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease, and type 2 diabetes. It integrates clinically validated polygenic risk scores with non-genetic elements like age, family history, and clinical readings to offer a customized, actionable risk profile. Intended for proactive health management, it also furnishes clear reports containing personalized recommendations to direct preventive care and lifestyle choices across over 42 countries.
Who Are The Companies Operating Across The Predictive Genetic Counselling Market Value Chain?
Major companies operating in the predictive genetic counselling market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Natera Inc, Myriad Genetics Inc., Fulgent Genetics Inc, Invitae Corporation, 23andMe Holding Co, Color Genomics Inc, deCODE genetics, Centogene NV, Admera Health LLC, Mapmygenome, Exact Sciences Corporation, BGI Group
Get The Full Predictive Genetic Counselling Market Report:
Which Region Represents The Largest Share Of The Predictive Genetic Counselling Market?
North America was the largest region in the predictive genetic counselling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic counselling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Predictive Genetic Counselling Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Predictive Genetic Counselling Market 2026, By The Business Research Company
Rapid Strength Concrete Market Report 2026
https://www.thebusinessresearchcompany.com/report/rapid-strength-concrete-global-market-report
Latex Mattress Market Report
https://www.thebusinessresearchcompany.com/report/latex-mattress-global-market-report
Concrete Materials Market Report
https://www.thebusinessresearchcompany.com/report/concrete-materials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model